Novavax

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Novavax 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. 

CEO
John C.s Jacobs
CEOJohn C.s Jacobs
Employees
749
Employees749
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1987
Founded1987
Employees
749
Employees749

NVAX Key Statistics

Market cap
1.54B
Market cap1.54B
Price-Earnings ratio
-15.65
Price-Earnings ratio-15.65
Dividend yield
Dividend yield
Average volume
4.46M
Average volume4.46M
High today
$9.70
High today$9.70
Low today
$9.13
Low today$9.13
Open price
$9.49
Open price$9.49
Volume
2.96M
Volume2.96M
52 Week high
$11.97
52 Week high$11.97
52 Week low
$6.20
52 Week low$6.20

Stock Snapshot

The current Novavax(NVAX) stock price is $9.31, with a market capitalization of 1.54B. The stock trades at a price-to-earnings (P/E) ratio of -15.65.

As of 2026-07-07, Novavax(NVAX) stock has fluctuated between $9.13 and $9.70. The current price stands at $9.31, placing the stock +2.0% above today's low and -4.0% off the high.

The Novavax(NVAX)'s current trading volume is 2.96M, compared to an average daily volume of 4.46M.

During the past year, Novavax(NVAX) stock moved between $6.20 at its lowest and $11.97 at its peak.

During the past year, Novavax(NVAX) stock moved between $6.20 at its lowest and $11.97 at its peak.

NVAX News

Simply Wall St 1d
Does Novavax’s Russell Exit Quietly Recast Its Partnership-Driven, Royalty-Focused Equity Story?

On 27 June 2026, Novavax, Inc. was removed from multiple Russell growth indices, including the Russell 2000 Growth and Russell 3000 Growth, reflecting index reb...

Does Novavax’s Russell Exit Quietly Recast Its Partnership-Driven, Royalty-Focused Equity Story?
Simply Wall St 3d
Novavax After Russell Index Exits Is The Undervalued View Already Priced In

Advertisement Index removals put Novavax in focus for passive and active investors Novavax (NVAX) was recently dropped from several Russell growth benchmarks,...

Novavax After Russell Index Exits Is The Undervalued View Already Priced In

Analyst ratings

56%

of 9 ratings
Buy
55.6%
Hold
11.1%
Sell
33.3%

People also own

Based on the portfolios of people who own NVAX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.